This points to a pro-survival role of SOX9 in chondrosarcoma cells during early cancer stages, promoting tumor development, growth and progression, but at the same time, SOX9 may act as an inhibitor for progression into dedifferentiated tissue. The gene discussed is SOX9; the disease is cancer.